ClinicalTrials.gov record
Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
ClinicalTrials.gov ID: NCT01335399
Public ClinicalTrials.gov record NCT01335399. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Subjects With Previously Untreated Multiple Myeloma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS)
Study identification
- NCT ID
- NCT01335399
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 748 participants
Conditions and interventions
Conditions
Interventions
- Lenalidomide Drug
- Dexamethasone Drug
- Elotuzumab (BMS-901608; HuLuc63) Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 3, 2011
- Primary completion
- Sep 30, 2019
- Completion
- Sep 2, 2021
- Last update posted
- Sep 29, 2022
2011 – 2021
United States locations
- U.S. sites
- 88
- U.S. states
- 32
- U.S. cities
- 73
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 1628 | Birmingham | Alabama | 35243 | — |
| Local Institution - 7619 | Mobile | Alabama | 36604 | — |
| Local Institution - 7618 | Mobile | Alabama | 36608 | — |
| Local Institution - 7617 | Chandler | Arizona | 85224 | — |
| Local Institution - 1644 | Tucson | Arizona | 85715 | — |
| Local Institution - 1618 | Bakersfield | California | 93309 | — |
| Local Institution - 1602 | Berkeley | California | 94704 | — |
| Local Institution - 1636 | Corona | California | 92879 | — |
| Local Institution - 1668 | Corona | California | 92879 | — |
| Local Institution - 1616 | Greenbrae | California | 94904 | — |
| Local Institution - 7609 | Long Beach | California | 90813 | — |
| Local Institution - 1660 | Los Angeles | California | 90095 | — |
| Local Institution - 1673 | Orange | California | 92868 | — |
| Local Institution - 1613 | San Diego | California | 92123 | — |
| Local Institution - 1621 | New Haven | Connecticut | 06520 | — |
| Local Institution - 1612 | Washington D.C. | District of Columbia | 20010 | — |
| Local Institution - 1682 | Boca Raton | Florida | 33486 | — |
| Local Institution - 1617 | Brooksville | Florida | 34613 | — |
| Local Institution - 1648 | Fort Myers | Florida | 33916 | — |
| Local Institution - 7613 | Hollywood | Florida | 33021 | — |
| Local Institution - 1623 | Jacksonville | Florida | 32256 | — |
| Local Institution - 1625 | New Port Richey | Florida | 34652 | — |
| Local Institution - 1649 | St. Petersburg | Florida | 33705 | — |
| Local Institution - 1611 | West Palm Beach | Florida | 33401 | — |
| Local Institution - 1630 | Atlanta | Georgia | 30322 | — |
| Local Institution - 1684 | Honolulu | Hawaii | 96819 | — |
| Local Institution - 1607 | Chicago | Illinois | 19123 | — |
| Local Institution - 1635 | Chicago | Illinois | 60612 | — |
| Local Institution - 1632 | Maywood | Illinois | 60153 | — |
| Local Institution - 7606 | Peoria | Illinois | 61615 | — |
| Local Institution - 7610 | Skokie | Illinois | 60077 | — |
| Local Institution - 1603 | Urbana | Illinois | 61801 | — |
| Local Institution - 7616 | Bloomington | Indiana | 47403 | — |
| Local Institution - 7620 | Indianapolis | Indiana | 46237 | — |
| Local Institution - 1669 | Indianapolis | Indiana | 46260 | — |
| Local Institution - 1656 | Mishawaka | Indiana | 46545 | — |
| Local Institution - 1633 | Iowa City | Iowa | 52242 | — |
| Local Institution - 1674 | Lexington | Kentucky | 40503 | — |
| Local Institution - 1683 | Louisville | Kentucky | 40207 | — |
| Local Institution - 1646 | Lafayette | Louisiana | 70503 | — |
| Local Institution - 7614 | Marrero | Louisiana | 70072 | — |
| Local Institution - 1626 | New Orleans | Louisiana | 70121 | — |
| Local Institution - 1652 | Shreveport | Louisiana | 71103 | — |
| Local Institution - 1676 | Baltimore | Maryland | 21204 | — |
| Local Institution - 1650 | Baltimore | Maryland | 21237 | — |
| Local Institution - 1619 | Boston | Massachusetts | 02215 | — |
| Local Institution - 1699 | Boston | Massachusetts | 02215 | — |
| Local Institution - 1604 | Detroit | Michigan | 48202 | — |
| Local Institution - 1667 | Jefferson City | Missouri | 65101 | — |
| Local Institution - 1651 | Springfield | Missouri | 65804 | — |
| Local Institution - 1645 | St Louis | Missouri | 63110 | — |
| Local Institution - 1637 | Omaha | Nebraska | 68198-7680 | — |
| Local Institution - 7621 | Mineola | New York | 11501 | — |
| Local Institution - 1615 | New York | New York | 10019 | — |
| Local Institution - 1671 | Stony Brook | New York | 11794-8183 | — |
| Local Institution - 7604 | Goldsboro | North Carolina | 27534 | — |
| Local Institution - 1610 | Winston-Salem | North Carolina | 27103 | — |
| Local Institution - 1608 | Cleveland | Ohio | 44195 | — |
| Local Institution - 1693 | Cleveland | Ohio | 44195 | — |
| Local Institution - 1638 | Columbus | Ohio | 43210 | — |
| Local Institution - 1664 | Columbus | Ohio | 43219 | — |
| Local Institution - 1690 | Middletown | Ohio | 45042 | — |
| Local Institution - 1655 | Tulsa | Oklahoma | 74146 | — |
| Local Institution - 7611 | Langhorne | Pennsylvania | 19047 | — |
| Local Institution - 1647 | Pittsburgh | Pennsylvania | 15224 | — |
| Local Institution - 1679 | Pittsburgh | Pennsylvania | 15240 | — |
| Local Institution - 1677 | Sayre | Pennsylvania | 18840 | — |
| Local Institution - 1629 | Charleston | South Carolina | 29414 | — |
| Local Institution - 7615 | Charleston | South Carolina | 29425 | — |
| Local Institution - 1624 | Greenville | South Carolina | 29615 | — |
| Local Institution - 7607 | Sioux Falls | South Dakota | 57105 | — |
| Local Institution - 1600 | Knoxville | Tennessee | 37909 | — |
| Local Institution - 7628 | Memphis | Tennessee | 38120 | — |
| Local Institution - 1627 | Nashville | Tennessee | 37203 | — |
| Local Institution - 1670 | Nashville | Tennessee | 37232-5505 | — |
| Local Institution - 1634 | Corpus Christi | Texas | 78412 | — |
| Local Institution - 7612 | Dallas | Texas | 75246 | — |
| Local Institution - 1643 | Houston | Texas | 77030 | — |
| Local Institution - 1686 | Houston | Texas | 77030 | — |
| Local Institution - 1642 | Houston | Texas | 77090 | — |
| Local Institution - 7623 | Ogden | Utah | 84405 | — |
| Local Institution - 1657 | Fredericksburg | Virginia | 22408 | — |
| Local Institution - 1640 | Seattle | Washington | 98108 | — |
| Local Institution - 1631 | Seattle | Washington | 98109 | — |
| Local Institution - 1601 | Huntington | West Virginia | 25701 | — |
| Gundersen Clinic, Ltd | La Crosse | Wisconsin | 54601 | — |
| Local Institution - 1663 | Madison | Wisconsin | 53717 | — |
| Local Institution - 1609 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 147 non-U.S. sites.
Recently updated Multiple Myeloma trials
Other public records listing Multiple Myeloma. Sorted by last update posted; newest first. Not a recommendation.
- NCT05201781: A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel Recruiting
- NCT07783607: MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma Not yet recruiting
- NCT06152575: MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) Recruiting
- NCT07776964: Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) Not yet recruiting
- NCT07285239: Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Recruiting
- NCT05976555: Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01335399, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 29, 2022 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01335399 live on ClinicalTrials.gov.